[Pathological features of immune-mediated hepatitis due to immune checkpoint inhibitors and anti-angiogenesis targeted therapy]

Authors :: Q Y, Zhang
L L, Chen
F, Gao
Akesu, Sujie
Y Y, Hou
X W, Huang
C, Huang
H C, Sun
J, Zhou
Y, Ji
Source :: Zhonghua bing li xue za zhi = Chinese journal of pathology. 49(4)
Publication Year :: 2020

Subjects :: Neovascularization, Pathologic
Endothelial Cells
Humans
Antineoplastic Agents
Immunotherapy
Protein Kinase Inhibitors
Hepatitis

Tools